Mepolizumab

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Mepolizumab and local guidelines before prescribing.

Anti-IL-5 monoclonal antibody

Mechanism

Anti-IL-5 monoclonal antibody.

Uses

Severe eosinophilic asthma, EGPA, hypereosinophilic syndrome.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Headache, injection-site reaction, back pain, herpes zoster.

Interactions

Few.

Contraindications and cautions

Active parasitic infection

Monitoring

Eosinophils, asthma control

Pregnancy and breastfeeding

Limited data

Renal and hepatic impairment

No adjustment

Overdose and reversal

Supportive

Special advice

Treat helminth infections first; do not stop inhaled steroids abruptly.

More from the textbook: uses, cautions and other points
Where it is discussed in the book